Literature DB >> 19054785

Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers.

Päivikki Alatalo1, Heidi Koivisto, Katri Puukka, Johanna Hietala, Petra Anttila, Risto Bloigu, Onni Niemelä.   

Abstract

AIMS: Although a wide variety of biomarkers reflecting liver status are known to be influenced by excessive ethanol consumption, the dose-response relationships between ethanol intake and marker changes have remained less understood.
METHODS: Serum gamma-glutamyltransferase (GGT), aspartate aminotransferase (AST), alanine aminotransferase (ALT) activities, and ferritin and albumin protein concentrations were compared in a large population of heavy drinkers (105 men, 28 women), moderate drinkers (781 men, 723 women) and abstainers (252 men, 433 women), who were devoid of apparent liver disease.
RESULTS: In heavy drinkers, serum GGT, AST, ALT, ferritin and albumin were all significantly higher than in moderate drinkers or abstainers (P < 0.001 for all comparisons). The highest incidences of elevated values were found for GGT (62%) followed by AST (53%), ALT (39%), ferritin (34%) and albumin (20%). Serum GGT (P < 0.001), ALT (P < 0.01) and ferritin (P < 0.05) in moderate drinkers were also higher than the levels observed in abstainers. When the study population was further divided into subgroups according to gender, significant differences between moderate drinkers and abstainers in GGT and ALT were noted in men whereas not in women.
CONCLUSIONS: The data demonstrate that biomarkers of alcohol abuse and liver function may respond to even rather low levels of ethanol intake in a gender-dependent manner, which should be implicated in studies on the early-phase interactions of ethanol and the liver and in the definition of normal ranges for such biomarkers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19054785     DOI: 10.1093/alcalc/agn099

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  17 in total

1.  Advancing alcohol biomarkers research.

Authors:  Cynthia F Bearer; Shannon M Bailey; Jan B Hoek
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

2.  Depression inhibits the anti-inflammatory effects of leisure time physical activity and light to moderate alcohol consumption.

Authors:  Edward C Suarez; Nicole L Schramm-Sapyta; Tracey Vann Hawkins; Alaattin Erkanli
Journal:  Brain Behav Immun       Date:  2013-03-26       Impact factor: 7.217

3.  Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults.

Authors:  James Tsai; Earl S Ford; Guixiang Zhao; Chaoyang Li; Kurt J Greenlund; Janet B Croft
Journal:  J Behav Med       Date:  2011-05-28

4.  Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank.

Authors:  Frederick K Ho; Lyn D Ferguson; Carlos A Celis-Morales; Stuart R Gray; Ewan Forrest; William Alazawi; Jason Mr Gill; Srinivasa Vittal Katikireddi; John Gf Cleland; Paul Welsh; Jill P Pell; Naveed Sattar
Journal:  EClinicalMedicine       Date:  2022-05-12

5.  Alcohol, metabolic risk and elevated serum gamma-glutamyl transferase (GGT) in Indigenous Australians.

Authors:  Matthew T Haren; Ming Li; John Petkov; Robyn A McDermott
Journal:  BMC Public Health       Date:  2010-08-03       Impact factor: 3.295

6.  Metabolic and biochemical effects of low-to-moderate alcohol consumption.

Authors:  John B Whitfield; Andrew C Heath; Pamela A F Madden; Michele L Pergadia; Grant W Montgomery; Nicholas G Martin
Journal:  Alcohol Clin Exp Res       Date:  2012-11-07       Impact factor: 3.455

7.  Serum Gamma-Glutamyltransferase Levels Predict Clinical Outcomes in Hemodialysis Patients.

Authors:  Woo Yeong Park; Eun Sil Koh; Su-Hyun Kim; Young Ok Kim; Dong Chan Jin; Ho Chul Song; Euy Jin Choi; Yong-Lim Kim; Yon-Su Kim; Shin-Wook Kang; Nam-Ho Kim; Chul Woo Yang; Yong Kyun Kim
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

8.  Classical blood biomarkers identify patients with higher risk for relapse 6 months after alcohol withdrawal treatment.

Authors:  Florian J Raabe; Elias Wagner; Eva Hoch; Gabriele Koller; Judith Weiser; Sarah Brechtel; David Popovic; Kristina Adorjan; Oliver Pogarell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-07-05       Impact factor: 5.270

9.  Assessing alcohol intake & its dose-dependent effects on liver enzymes by 24-h recall and questionnaire using NHANES 2001-2010 data.

Authors:  Sanjiv Agarwal; Victor L Fulgoni; Harris R Lieberman
Journal:  Nutr J       Date:  2016-06-22       Impact factor: 3.271

Review 10.  Biomarker-Based Approaches for Assessing Alcohol Use Disorders.

Authors:  Onni Niemelä
Journal:  Int J Environ Res Public Health       Date:  2016-01-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.